Your session is about to expire
← Back to Search
Anticoagulants for Atrial Fibrillation (PIAAFRx Trial)
PIAAFRx Trial Summary
This trial will compare the effectiveness of oral anticoagulation therapy prescribed by a pharmacist intervention versus enhanced usual care in people with unrecognized or known AF who are not currently taking blood thinners.
- Atrial Fibrillation
- Stroke
PIAAFRx Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 4 trial • 206 Patients • NCT02984982PIAAFRx Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your blood pressure is consistently very high (average of 160 mmHg or more).You have very poor kidney function.You have atrial fibrillation and are not taking the right medication to prevent blood clots.You have had bleeding inside your brain at any time.You have a specific type of heart valve problem, including a prosthetic valve or moderate to severe mitral stenosis.You drink a lot of alcohol each week, more than 28 units if you're a male or more than 21 units if you're a female.You have experienced serious bleeding that required hospitalization or happened in critical places like the brain or spine.You have serious trouble with memory and thinking.You are at least 65 years old and have at least one additional risk factor for stroke, such as high blood pressure, diabetes, heart failure, a history of stroke or mini-stroke, or a weak heart.You have atrial fibrillation but are not taking medication to prevent blood clots.
- Group 1: Enhanced Usual Care Arm
- Group 2: Active Pharmacist Arm
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA sanctioned Anticoagulants for clinical application?
"Following a thorough evaluation, the safety rating of anticoagulants was set at 3 due to their status as an FDA-approved medication."
What other research initiatives have been taken to explore the applications of anticoagulants?
"Currently, 26 clinical trials looking into anticoagulants are underway. 9 of those investigations are in the final stage before approval and Montreal is the primary site for these studies with a total of 379 locations running them."
Are there any opportunities for volunteers to participate in the clinical trial?
"This trial, posted on February 1st 2018 and last edited August 8th 2022 is not currently recruiting participants. However, a total of 1494 other medical trials are actively seeking out patients at this moment in time."
What are the common medical conditions for which Anticoagulants is prescribed?
"Anticoagulants have a variety of applications, such as managing thromboembolism and prophylactically preventing venous thrombosis, cerebrovascular accident, or problems with mechanical heart valves."
How many participants are currently being enrolled in this clinical trial?
"This investigation is not actively searching for individuals at present. Initially posted on the first day of February 2018 and most recently edited on the 8th August 2022, it is no longer accepting new participants. Nevertheless, if you are seeking other studies with a similar focus, there are 1468 clinical trials related to stroke currently open and 26 experiments involving anticoagulants that have active recruitment periods."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger